These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 8958222)
1. Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32. Adjei PN; Kaufmann SH; Leung WY; Mao F; Gores GJ J Clin Invest; 1996 Dec; 98(11):2588-96. PubMed ID: 8958222 [TBL] [Abstract][Full Text] [Related]
2. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases. Shimizu T; Pommier Y Leukemia; 1997 Aug; 11(8):1238-44. PubMed ID: 9264376 [TBL] [Abstract][Full Text] [Related]
3. Merbarone, a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE/CED-3-like protease. Khélifa T; Beck WT Mol Pharmacol; 1999 Mar; 55(3):548-56. PubMed ID: 10051540 [TBL] [Abstract][Full Text] [Related]
4. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Eischen CM; Kottke TJ; Martins LM; Basi GS; Tung JS; Earnshaw WC; Leibson PJ; Kaufmann SH Blood; 1997 Aug; 90(3):935-43. PubMed ID: 9242521 [TBL] [Abstract][Full Text] [Related]
5. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis. Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760 [TBL] [Abstract][Full Text] [Related]
6. Detection of apoptosis induced by topoisomerase inhibitors and serum deprivation in syrian hamster embryo cells. Alexandre S; Rast C; Nguyen-Ba G; Vasseur P Exp Cell Res; 2000 Feb; 255(1):30-9. PubMed ID: 10666331 [TBL] [Abstract][Full Text] [Related]
7. Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes. Inayat-Hussain SH; Couet C; Cohen GM; Cain K Hepatology; 1997 Jun; 25(6):1516-26. PubMed ID: 9185777 [TBL] [Abstract][Full Text] [Related]
8. DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies. Shimizu T; Pommier Y Exp Cell Res; 1996 Aug; 226(2):292-301. PubMed ID: 8806433 [TBL] [Abstract][Full Text] [Related]
9. Ectopic p16(ink4) expression enhances CPT-11-induced apoptosis through increased delay in S-phase progression in human non-small-cell-lung-cancer cells. Fukuoka K; Nishio K; Fukumoto H; Arioka H; Kurokawa H; Ishida T; Iwamoto Y; Tomonari A; Suzuki T; Usuda J; Narita N; Saijo N Int J Cancer; 2000 Apr; 86(2):197-203. PubMed ID: 10738246 [TBL] [Abstract][Full Text] [Related]
10. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells. Schmitt E; Steyaert A; Cimoli G; Bertrand R Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502 [TBL] [Abstract][Full Text] [Related]
11. Actin cleavage by CPP-32/apopain during the development of apoptosis. Mashima T; Naito M; Noguchi K; Miller DK; Nicholson DW; Tsuruo T Oncogene; 1997 Mar; 14(9):1007-12. PubMed ID: 9070648 [TBL] [Abstract][Full Text] [Related]
12. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. Dubrez L; Savoy I; Hamman A; Solary E EMBO J; 1996 Oct; 15(20):5504-12. PubMed ID: 8896444 [TBL] [Abstract][Full Text] [Related]
13. Caspase activation in MCF7 cells responding to etoposide treatment. Benjamin CW; Hiebsch RR; Jones DA Mol Pharmacol; 1998 Mar; 53(3):446-50. PubMed ID: 9495810 [TBL] [Abstract][Full Text] [Related]
15. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities. Sané AT; Bertrand R Cancer Res; 1998 Jul; 58(14):3066-72. PubMed ID: 9679972 [TBL] [Abstract][Full Text] [Related]
16. Processing/activation of at least four interleukin-1beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. MacFarlane M; Cain K; Sun XM; Alnemri ES; Cohen GM J Cell Biol; 1997 Apr; 137(2):469-79. PubMed ID: 9128256 [TBL] [Abstract][Full Text] [Related]
17. Multiple proteases are involved in thymocyte apoptosis. Zhivotovsky B; Gahm A; Ankarcrona M; Nicotera P; Orrenius S Exp Cell Res; 1995 Dec; 221(2):404-12. PubMed ID: 7493640 [TBL] [Abstract][Full Text] [Related]
18. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166 [TBL] [Abstract][Full Text] [Related]
19. Baculovirus P35 inhibits the glucocorticoid-mediated pathway of cell death. Robertson NM; Zangrilli J; Fernandes-Alnemri T; Friesen PD; Litwack G; Alnemri ES Cancer Res; 1997 Jan; 57(1):43-7. PubMed ID: 8988038 [TBL] [Abstract][Full Text] [Related]
20. Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells. Posmantur R; McGinnis K; Nadimpalli R; Gilbertsen RB; Wang KK J Neurochem; 1997 Jun; 68(6):2328-37. PubMed ID: 9166725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]